Drugs & Aging

, Volume 35, Issue 5, pp 375–377 | Cite as

Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and Research

  • Lorenz Van der Linden
  • Julie Hias
  • Karolien Walgraeve
  • Johan Flamaing
  • Isabel Spriet
  • Jos Tournoy

Potentially inappropriate prescribing (PIP) remains prevalent in older adults, whether pertaining to over-, mis-, or under-prescribing [1, 2]. Both polypharmacy and PIP have been correlated with an increased risk of iatrogenic harm such as unplanned hospital admissions [2]. This risk might be mitigated by implementing strategies to reduce PIP. These strategies frequently comprise a comprehensive medication review and the involvement of ward-based clinical pharmacists [3, 4, 5].

An overwhelming majority of interventional studies have been designed and powered specifically to detect an improvement in drug use. As a result, the effect on clinical outcomes, including hospital readmissions, remains scarce as recent evidence under the form of systematic reviews or meta-analyses failed to show a reduction in hospital readmissions after a pharmacist intervention in older inpatients [3, 5, 6, 7, 8, 9].

In this setting, the work of Gillespie et al. [10] should be highlighted as their randomized...


Compliance with Ethical Standards


No funding was received for the preparation of this manuscript.

Conflict of interest

L. Van der Linden, J. Hias, K. Walgraeve, J. Flamaing, I. Spriet, and J. Tournoy have no conflicts of interest relevant to the content of this article.


  1. 1.
    Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.CrossRefPubMedGoogle Scholar
  2. 2.
    Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–92.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;2:CD008986.PubMedGoogle Scholar
  4. 4.
    Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.CrossRefPubMedGoogle Scholar
  5. 5.
    Renaudin P, Boyer L, Esteve MA, Bertault-Peres P, Auquier P, Honore S. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(6):1660–73.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.CrossRefPubMedGoogle Scholar
  7. 7.
    Hohl CM, Wickham ME, Sobolev B, Perry JJ, Sivilotti ML, Garrison S, et al. The effect of early in-hospital medication review on health outcomes: a systematic review. Br J Clin Pharmacol. 2015;80(1):51–61.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165.Google Scholar
  9. 9.
    Johansson T, Abuzahra ME, Keller S, Mann E, Faller B, Sommerauer C, et al. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(2):532–48.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.CrossRefPubMedGoogle Scholar
  11. 11.
    Van der Linden L, Decoutere L, Walgraeve K, Milisen K, Flamaing J, Spriet I, et al. Combined use of the rationalization of home medication by an Adjusted STOPP in older Patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging. 2017;34(2):123–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857–66.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Hazen AC, Sloeserwij VM, Zwart DL, de Bont AA, Bouvy ML, de Gier JJ, et al. Design of the POINT study: pharmacotherapy optimisation through integration of a non-dispensing pharmacist in a primary care Team (POINT). BMC Fam Pract. 2015;2(16):76.CrossRefGoogle Scholar
  14. 14.
    Renaudin P, Baumstarck K, Daumas A, Esteve MA, Gayet S, Auquier P, et al. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial. Trials. 2017;18(1):65.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Gallagher J, O’Sullivan D, McCarthy S, Gillespie P, Woods N, O’Mahony D, et al. Structured pharmacist review of medication in older hospitalised patients: a cost-effectiveness analysis. Drugs Aging. 2016;33(4):285–94.CrossRefPubMedGoogle Scholar
  16. 16.
    Portela MC, Pronovost PJ, Woodcock T, Carter P, Dixon-Woods M. How to study improvement interventions: a brief overview of possible study types. BMJ Qual Saf. 2015;24(5):325–36.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Pellegrin KL, Krenk L, Oakes SJ, Ciarleglio A, Lynn J, McInnis T, et al. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J Am Geriatr Soc. 2017;65(1):212–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Pharmacy DepartmentUniversity Hospitals LeuvenLouvainBelgium
  2. 2.Department of Pharmaceutical and Pharmacological SciencesKU LeuvenLouvainBelgium
  3. 3.Department of Geriatric MedicineUniversity Hospitals LeuvenLouvainBelgium
  4. 4.Department of Chronic Diseases, Metabolism and AgeingKU LeuvenLouvainBelgium

Personalised recommendations